Loading asset research
Milestone Pharmaceuticals Inc. Common Shares
MISTNasdaq · USD · StocksQuote as of · Exchange session not verified$0.98
-6.67%
Today
MIST
Loading 1D prices…
Market cap
$122M
Volume
3.3M
52w high
$3.0652w low
$0.98Company profile
Milestone Pharmaceuticals Inc. Common Shares
Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines in the United States and Canada. It offers CARDAMYST (etripamil) nasal spray, a prescription medication for the conversion of acute symptomatic episodes of paroxysmal supraventricular tachycardia (PSVT) to sinus rhythm in adults. The company is also developing etripamil for the indication of atrial fibrillation with rapid ventricular rate (AFib-RVR). It has a license and collaboration agreement with Corxel Pharmaceuticals to develop and commercialize etripamil. Milestone Pharmaceuticals Inc.was incorporated in 2003 and is headquartered in Montreal, Canada.
Sector
Health Care
Industry
Pharmaceutical Preparations
Exchange
Nasdaq
Display currency
USD
Location
Montreal, QC, United States
Employees
38
Fiscal year end
1231
CIK
1408443
Session & valuation
Open$1.06
Previous close$1.05
Day high$1.08
Day low$0.98
30-day avg. volume1.6M
Outstanding shares124.5M
Diluted EPS-$0.75
Latest annual period
P/E (trailing)-1.31
P/E (forward)-1.27
Price / book7.60
Beta0.98
Dividend yield—
Deterministic peer set
Companies with SEC SIC 2834
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| TLSATiziana Life Sciences Ltd. Common Shares | $122.2M | $0.00 | — | -$0.16 | 0.00% | Buy |
| PMNProMIS Neurosciences Inc. Common Shares (ON) | $121.6M | $0.00 | — | -$22.61 | +1.19% | Buy |
| OKUROnKure Therapeutics Inc. Class A Common Stock | $125.5M | $0.00 | — | -$4.40 | -5.20% | Buy |
| RFLRafael Holdings Inc. Class B Common Stock | $118.6M | $630K | -3247.46% | -$0.40 | -3.39% | Unrated |
| RANIRani Therapeutics Holdings Inc. Class A Common Stock | $118.4M | $1.6M | -1817.09% | -$0.45 | +2.55% | Buy |